Profil
Ying joined HealthQuest in 2017 as Finance/Operations Analyst.
Prior to joining, she was part of Global Supply Chain at Cepheid responsible for reporting and forecasting.
She started her career working in laboratories at San Diego where she graduated from UC San Diego with a B.S.
in Biochemistry/Cell Biology.
Ying received her MBA from Santa Clara University where she was also a graduate teaching assistant.
Postes actifs de Ying Liang
| Sociétés | Poste | Début |
|---|---|---|
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital invests in companies located in the United States. The firm focuses on services, healthcare IT, medical devices, diagnostics and pharma services. It participates in growth stage transactions with an investment size of USD 20 - 100 million. The firm also makes co-investments and acts as a lead investor. | Analyste en capital-investissement | - |
Anciens postes connus de Ying Liang
| Sociétés | Poste | Fin |
|---|---|---|
| CEPHEID | Analyste en capital-investissement | 01/03/2017 |
Formation de Ying Liang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
CEPHEID
CEPHEID Medical SpecialtiesHealth Technology Develops, manufactures and markets molecular diagnostic systems | Health Technology |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital invests in companies located in the United States. The firm focuses on services, healthcare IT, medical devices, diagnostics and pharma services. It participates in growth stage transactions with an investment size of USD 20 - 100 million. The firm also makes co-investments and acts as a lead investor. | Finance |
















